$241.00
+1.92 (+0.80%)
At Close: Jun 24, 2026
J&J's (JNJ) DePuy Synthes' TriLEAP System to Aid Ankle Surgery
02:06pm, Friday, 09'th Aug 2024
Johnson & Johnson's (JNJ) DePuy Synthes announces the launch of its TriLEAP System, which is likely to provide better orthopedic solutions to foot and ankle surgeons.
2 Healthcare Stocks to Buy Hand Over Fist in August
06:02am, Friday, 09'th Aug 2024
Eli Lilly is a leader in diabetes and obesity care, but it's also making progress elsewhere. Johnson & Johnson has a robust underlying business, and a rare and ongoing dividend streak.
3 High-Yield Dividend Stocks to Buy and Hold Forever
05:29am, Friday, 09'th Aug 2024
Ford's dividend is high-yield, and unique thanks to family ownership. Altria Group is transitioning to smokeless tobacco, but its dividend remains a top option.
Nasdaq Sell-Off: 5 Unstoppable Stocks to Buy That Can Protect Your Principal and Grow Your Wealth in an Unpredictable Market
04:06am, Friday, 09'th Aug 2024
The Nasdaq Composite shed almost 1,400 points in a three-day stretch, which decisively pushed this growth-oriented index into correction territory. Heightened volatility on Wall Street is no reason fo
The 3 Best Dividend Aristocrats to Buy for Sustainable Income: August 2024
07:00am, Thursday, 08'th Aug 2024
Dividends have played a significant role in the total returns of equity investments. The practice of consistently increasing dividends can be seen in the S&P 500 Dividend Aristocrats.
Nipocalimab delayed or prevented severe fetal anemia and 54 percent of study participants in the Phase 2 UNITY study achieved a live birth at or after 32 weeks without the need for intrauterine transf
Is Trending Stock Johnson & Johnson (JNJ) a Buy Now?
10:02am, Wednesday, 07'th Aug 2024
Recently, Zacks.com users have been paying close attention to Johnson & Johnson (JNJ). This makes it worthwhile to examine what the stock has in store.
3 Dividend Growth Stocks to Buy Hand Over Fist in August
05:10am, Wednesday, 07'th Aug 2024
Abbott Labs is a proven wealth builder at a fair price. Johnson & Johnson's a safe buy despite its ongoing litigation.
4 Dividend Aristocrats To Buy In August And More To Watch
12:21pm, Tuesday, 06'th Aug 2024
“Dividend Aristocrats
3 Dividend Growth Stocks to Accumulate on Dips: August Edition
06:17am, Tuesday, 06'th Aug 2024
Dividend-paying stocks are ideal for outperforming the market or generating passive income. Finding dividend growth stocks, companies that have shown the ability and willingness to raise their distrib
3 Defensive Stocks Weathering the Market Storm
09:31am, Monday, 05'th Aug 2024
In a week where fear, uncertainty, and widespread selling swept the market, three stocks stood out for their resilience: Johnson & Johnson NYSE: JNJ, Coca-Cola NYSE: KO, and Procter & Gamble NYSE: PG.
3 stocks to counter a recession, according to ChatGPT4-o
05:51am, Monday, 05'th Aug 2024
The most recent U.S. jobs report published on Friday, August 2, gave investors a fright, as evidenced by the massive bloodbath in both the stock market and across the cryptocurrency markets, with the
5 Relatively Secure And Cheap Dividend Stocks To Invest In -- August 2024
09:00am, Saturday, 03'rd Aug 2024
This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering large discounts to their historical norms. We go over our filtering pr
Bargain-Hunters Paradise: 7 Value Stocks That Are Too Cheap to Ignore
10:00am, Thursday, 01'st Aug 2024
The market consistently offers opportunities in value stocks for bargain hunters willing to do the work and take risks. Most of the work is done here for you as I have identified value stocks that are
NEWARK, CA / ACCESSWIRE / August 1, 2024 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today announced publication of preclinical and phase 1 clinical data on JNJ-2113 in the journ
Sign In
Buy JNJ